Check back soon for more videos.
IRIDEX is a worldwide leader in developing innovative and versatile laser-based medical systems for the ophthalmology market. The Company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit iridex.com.
MicroPulse Restores Vision in DME Patient After Multiple Ineffective Anti-VEGF InjectionsDownload Case Study
MicroPulse Laser Therapy Resolves Persistent Fluid When Added to Anti-VEGF in AMD PatientDownload Case Study
Incorporating MicroPulse into a Comprehensive Practice: Durable Results that Ease Treatment Burden for Glaucoma and Retinal DiseaseDownload Case Study
MicroPulse Laser Therapy and Anti-VEGF Injections for Macular Edema Associated with CRVODownload Case Study